CXCL16 was significantly upregulated in kidney samples of PVAN patients as compared to patients with stable graft function in two of the four studies after false discovery rate (FDR) correction (Fig 6D and Table 1). The gene discussed is CXCL16; the disease is BK-virus nephropathy.